Results 21 to 30 of about 638,968 (308)

Determinants of Acceptance of Cervical Cancer Screening in Dar es Salaam, Tanzania. [PDF]

, 2012
To describe how demographic characteristics and knowledge of cervical cancer influence screening acceptance among women living in Dar es Salaam, Tanzania. Multistage cluster sampling was carried out in 45 randomly selected streets in Dar es Salaam. Women
A Hildesheim, AB Miller, AP Vizcaino, B Palanuwong, BA Johnson, Britt Tersbol, C Sepulveda, Crispin Kahesa, E Lazcano-Ponce, F Guidozzi, FX Bosch, H Nabudere, HL Kidanto, HR Wabinga, IARC, J Bradley, J Cuzick, J Ferlay, JBF Ferlay, Julius Mwaiselage, K Deodhar, L Denny, M Dartell, M Hakama, Myassa Dartell, N Munoz, P Autier, P Sasieni, Path, R Sankaranarayanan, SA Francis, SC Mupepi, SK Kjaer, SU Mbamara, Susanne Kjaer, T Ngoma, Twalib Ngoma, Vibeke Rasch, YL Qiao   +38 more
core   +2 more sources

Barriers to cervical screening participation in high-risk women [PDF]

, 2015
Aim Women aged 25–35 years, for whom cervical cancer is most problematic, are least likely to participate in the cervical screening programme. Therefore, identifying barriers to screening participation in this high-risk group is essential.
Lovell, Brian, Shepherd, Lee, Wetherell, Mark   +2 more
core   +1 more source

Associations between the signing status of family doctor contract services and cervical cancer screening behaviors: a cross-sectional study in Shenzhen, China

BMC Public Health, 2023
Background As a core part of the primary healthcare system, family doctor contract services (FDCS) may help healthcare providers promote cervical cancer screening to the female population.
Wei Lin, Weikang Huang, Chaofan Mei, Peiyi Liu, He Wang, Shixin Yuan, Xiaoshan Zhao, Yueyun Wang   +7 more
doaj   +1 more source

Human papillomavirus and HPV vaccines: a review [PDF]

, 2007
Cervical cancer, the most common cancer affecting women in developing countries, is caused by persistent infection with "high-risk" genotypes of human papillomaviruses (HPV). The most common oncogenic HPV genotypes are 16 and 18, causing approximately 70%
Castellsague, X., Claeys, P., Cutts, F. T., de Sanjose, S., Edmunds, W. J., Franceschi, S., Garnett, G., Goldenthal, K. L., Goldie, S., Harper, D. M., Markowitz, L.   +10 more
core   +3 more sources

Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review

BMC Women's Health, 2022
Objectives Low-and-middle-income countries (LMICs) bear a disproportionate burden of cervical cancer mortality. We aimed to identify what is currently known about barriers to cervical cancer screening among women in LMICs and propose remedial actions ...
Z. Petersen, A. Jaca, T. G. Ginindza, G. Maseko, S. Takatshana, P. Ndlovu, N. Zondi, N. Zungu, C. Varghese, G. Hunting, G. Parham, P. Simelela, S. Moyo   +12 more
doaj   +1 more source

Semantic Integration of Cervical Cancer Data Repositories to Facilitate Multicenter Association Studies: The ASSIST Approach [PDF]

, 2009
The current work addresses the unifi cation of Electronic Health Records related to cervical cancer into a single medical knowledge source, in the context of the EU-funded ASSIST research project.
Agorastos, Theodoros, Coorevits, Pascal, Delopoulos, Manolis, Kaufmann, Andreas M., Koutkias, Vassilis, Kurzeja, Roberto, Mitkas, Pericles A., Tantsis, Antonios, Weyers, Steven   +8 more
core   +2 more sources

Cervical Cancer Screening [PDF]

Medical Clinics of North America, 2017
Cervical cancer screening in the United States has accompanied profound decreases in cancer incidence and mortality over the last half century. Two screening strategies are currently endorsed by US-based guideline groups: (1) triennial cytology for women aged 21 to 65 years, and (2) triennial cytology for women aged 21 to 29 years followed by cytology ...
Sawaya, George F, Huchko, Megan J
openaire   +4 more sources

Cervical Cancer Screening [PDF]

Journal of the National Comprehensive Cancer Network, 2014
These NCCN Guidelines Insights focus on recent recommendations for cervical cancer screening and management of abnormal screening tests. When the NCCN Panel convened to update the NCCN Guidelines for Cervical Cancer Screening, they decided to adopt and endorse guidelines from other organizations to avoid duplication of effort.
Edward E, Partridge, Nadeem, Abu-Rustum, Anna, Giuliano, Stewart, Massad, Joan, McClure, Mary, Dwyer, Miranda, Hughes   +6 more
openaire   +4 more sources

Robotic-Assisted Transperitoneal Aortic Lymphadenectomy as Part of Staging Procedure for Gynaecological Malignancies: Single Institution Experience

Obstetrics and Gynecology International, 2013
Introduction. This study was designed to confirm the feasibility and safety of robotic-assisted transperitoneal aortic lymphadenectomy as part of staging procedure for gynecologic malignancies. Methods.
V. Zanagnolo, D. Rollo, T. Tomaselli, P. G. Rosenberg, L. Bocciolone, F. Landoni, G. Aletti, M. Peiretti, F. Sanguineti, A. Maggioni   +9 more
doaj   +1 more source

Pre-Procedural Anxiety and Associated Factors Among Women Seeking for Cervical Cancer Screening Services in Shenzhen, China: Does Past Screening Experience Matter?

Frontiers in Oncology, 2022
BackgroundResearch gaps exist in addressing the psychological harm related to the cervical cancer screening. Anxiety is the most common distress driven by the screening procedures, which may be affected by past screening experience (PSE) but with ...
Wei Lin, Wei Lin, Weikang Huang, Chaofan Mei, Chuyan Zhong, Leilei Zhu, Leilei Zhu, Peiyi Liu, Peiyi Liu, Shixin Yuan, Shixin Yuan, Zhihua Liu, Zhihua Liu, Yueyun Wang, Yueyun Wang, Yueyun Wang   +15 more
doaj   +1 more source